{"id":"https://openalex.org/W2031069291","doi":"https://doi.org/10.1248/bpb.33.1024","title":"2'-Deoxycytidine Decreases the Anti-tumor Effects of 5-Fluorouracil on Mouse Myeloma Cells","display_name":"2'-Deoxycytidine Decreases the Anti-tumor Effects of 5-Fluorouracil on Mouse Myeloma Cells","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2031069291","doi":"https://doi.org/10.1248/bpb.33.1024","mag":"2031069291","pmid":"https://pubmed.ncbi.nlm.nih.gov/20522971"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.33.1024","doi":"https://doi.org/10.1248/bpb.33.1024","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.33.1024","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/33/6/33_6_1024/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2031069291"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/bpb/33/6/33_6_1024/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061784911","display_name":"Ayano Iwazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ayano Iwazaki","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Setsunan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Setsunan University","institution_ids":["https://openalex.org/I102826571"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018652020","display_name":"Masanori Yoshioka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanori Yoshioka","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Setsunan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Setsunan University","institution_ids":["https://openalex.org/I102826571"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I102826571"],"apc_list":null,"apc_paid":null,"fwci":0.2082,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.45528227,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"33","issue":"6","first_page":"1024","last_page":"1027"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-deoxycytidine","display_name":"2'-deoxycytidine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7440000176429749},{"id":"https://openalex.org/keywords/myeloma-cells","display_name":"myeloma cells","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hypoxanthine-guanine-phosphoribosyltransferase","display_name":"hypoxanthine-guanine phosphoribosyltransferase","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pyrimidine-nucleosides","display_name":"pyrimidine nucleosides","score":0.8209999799728394},{"id":"https://openalex.org/keywords/chemotherapy-efficacy","display_name":"chemotherapy efficacy","score":0.5049999952316284},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.596769392490387},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.5457706451416016},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5201752185821533},{"id":"https://openalex.org/C2778301229","wikidata":"https://www.wikidata.org/wiki/Q169313","display_name":"Guanine","level":4,"score":0.48626387119293213},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48593369126319885},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47995617985725403},{"id":"https://openalex.org/C13576564","wikidata":"https://www.wikidata.org/wiki/Q6594591","display_name":"Pyrimidine analogue","level":3,"score":0.47399818897247314},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45979687571525574},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.4400838315486908},{"id":"https://openalex.org/C2777991568","wikidata":"https://www.wikidata.org/wiki/Q7187556","display_name":"Phosphoribosyltransferase","level":5,"score":0.43873023986816406},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.43249380588531494},{"id":"https://openalex.org/C78179603","wikidata":"https://www.wikidata.org/wiki/Q14864606","display_name":"Hypoxanthine-guanine phosphoribosyltransferase","level":4,"score":0.42765069007873535},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37771594524383545},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.3626210689544678},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35898351669311523},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3309621810913086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28871047496795654},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25672829151153564},{"id":"https://openalex.org/C512185932","wikidata":"https://www.wikidata.org/wiki/Q28745","display_name":"Nucleotide","level":3,"score":0.19815462827682495},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12601768970489502},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.08161425590515137},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006825","descriptor_name":"Hybridomas","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007041","descriptor_name":"Hypoxanthine Phosphoribosyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.33.1024","doi":"https://doi.org/10.1248/bpb.33.1024","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.33.1024","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/33/6/33_6_1024/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:20522971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20522971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.33.1024","doi":"https://doi.org/10.1248/bpb.33.1024","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.33.1024","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/33/6/33_6_1024/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321148","display_name":"Cairo University","ror":"https://ror.org/03q21mh05"},{"id":"https://openalex.org/F4320334796","display_name":"National Cancer Institute, Cairo University","ror":"https://ror.org/03q21mh05"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2031069291.pdf","grobid_xml":"https://content.openalex.org/works/W2031069291.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W91108901","https://openalex.org/W1553950610","https://openalex.org/W1607215393","https://openalex.org/W1742102714","https://openalex.org/W1854431912","https://openalex.org/W1963933128","https://openalex.org/W1974869964","https://openalex.org/W2004724058","https://openalex.org/W2008182609","https://openalex.org/W2015445088","https://openalex.org/W2018363764","https://openalex.org/W2022974257","https://openalex.org/W2037048614","https://openalex.org/W2043841745","https://openalex.org/W2062413760","https://openalex.org/W2067434510","https://openalex.org/W2073749796","https://openalex.org/W2083076360","https://openalex.org/W2087737282","https://openalex.org/W2099156657","https://openalex.org/W2120928958","https://openalex.org/W2122680090","https://openalex.org/W2127497086","https://openalex.org/W2129331232","https://openalex.org/W2324165948","https://openalex.org/W2421409900"],"related_works":["https://openalex.org/W2016248776","https://openalex.org/W1519644050","https://openalex.org/W2404265029","https://openalex.org/W2076653583","https://openalex.org/W2289426780","https://openalex.org/W4244443204","https://openalex.org/W1555951077","https://openalex.org/W1995961103","https://openalex.org/W12918740","https://openalex.org/W1992274500"],"abstract_inverted_index":{"2'-Deoxycytidine":[0],"(dCyd),":[1],"a":[2,16,25,33,146,159,192,208],"pyrimidine":[3,57],"nucleoside":[4,34],"found":[5],"at":[6],"high":[7],"concentrations":[8,48],"in":[9,43,124,133,142,151,176,200],"the":[10,70,81,86,134,143,152,185],"plasma":[11,46],"of":[12,73,83,88,122,149,188,205],"cancer":[13],"patients":[14,44],"with":[15,103,221],"poor":[17],"prognosis":[18],"after":[19],"chemotherapy,":[20],"is":[21,32,37,60,197,210],"considered":[22],"to":[23,137,165,170,212],"be":[24,76,138,158],"biomarker":[26,209],"for":[27,216],"breast":[28],"cancer.":[29],"5-Fluorouracil":[30],"(5FU)":[31],"analog":[35],"and":[36,54,100,127,190,218],"used":[38],"as":[39,207],"an":[40],"anti-tumor":[41,186],"agent":[42],"whose":[45],"dCyd":[47,53,84,123,163,183,206],"are":[49,56],"increased.":[50],"Because":[51],"both":[52,125],"5FU":[55,74,89,113,189],"analogues,":[58],"it":[59],"possible":[61,147],"that":[62,141,182,191],"they":[63],"have":[64],"pharmacokinetic/":[65],"pharmacodynamic":[66],"interaction,":[67,153],"by":[68,112,116],"which":[69],"anti-cancer":[71],"efficacy":[72,187],"would":[75],"reduced.":[77],"Here,":[78],"we":[79],"examined":[80],"effects":[82],"on":[85,90],"cytotoxicity":[87],"mouse":[91],"myeloma":[92],"SP2/0-Ag14":[93],"(SP2/0)":[94],"cells":[95],"lacking":[96],"hypoxanthine-guanine-phosphoribosyl":[97],"transferase":[98],"(HGPRT)":[99],"RH4":[101,128],"hybridomas":[102],"HGPRT":[104,150,196],"under":[105],"asynchronized":[106],"conditions.":[107],"The":[108,203],"reduced":[109],"cell":[110],"viability":[111],"was":[114],"restored":[115],"co-,":[117],"but":[118,130],"not":[119,157],"pre-,":[120],"treatment":[121],"SP2/0":[126,166],"cells,":[129],"this":[131,155,201],"effect":[132],"former":[135],"tended":[136,169],"greater":[139],"than":[140],"latter,":[144],"suggesting":[145],"involvement":[148],"although":[154],"might":[156],"major":[160],"mechanism.":[161],"Moreover,":[162],"administration":[164],"myeloma-bearing":[167],"mice":[168],"shorten":[171],"their":[172],"5FU-induced":[173],"prolonged":[174],"survival":[175],"vivo.":[177],"Collectively,":[178],"these":[179],"results":[180],"indicate":[181],"decreases":[184],"metabolic":[193],"pathway":[194],"via":[195],"involved":[198],"partially":[199],"interaction.":[202],"evaluation":[204],"believed":[211],"provide":[213],"valuable":[214],"information":[215],"effective":[217],"safe":[219],"chemotherapy":[220],"5FU.":[222]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2031069291","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}
